SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-053079
Filing Date
2021-10-15
Accepted
2021-10-15 17:08:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea148854-s1_boston.htm S-1 1784702
2 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF THE SERIES C PREFERRED ST ea148854ex3-5_boston.htm EX-3.5 100150
3 CONSENT OF M&K CPAS ea148854ex23-1_boston.htm EX-23.1 2632
4 GRAPHIC image_001.jpg GRAPHIC 7219
5 GRAPHIC ex23-1_001.jpg GRAPHIC 6698
  Complete submission text file 0001213900-21-053079.txt   1908006
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-260298 | Film No.: 211326638
SIC: 2834 Pharmaceutical Preparations